Blood coagulation abnormalities in chronic myeloid leukaemia

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT).

Bone marrow transplantation·2001

Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group.

Annals of oncology : official journal of the European Society for Medical Oncology·2001

Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia.

British journal of haematology·2001

Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies.

Leukemia·2001

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.

Leukemia·2001

Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.

Seminars in hematology·2001

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Haematologica·2026

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Haematologica·2026

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Haematologica·2026

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Haematologica·2026

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Haematologica·2026

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Haematologica·2026

Comparison of radial artery and saphenous vein as the third conduit with bilateral internal mammary arteries in coronary bypass surgery.

JTCVS open·2026

Hemiarch repair versus total-arch repair with frozen elephant trunk for acute type A aortic dissection: A propensity score-matched study.

JTCVS open·2026

Is systemic anticoagulation necessary during intraoperative venoarterial extracorporeal membrane oxygenation for bilateral lung transplantation? A feasibility study comparing zero-, low-, and high-intensity heparin strategies.

JTCVS open·2026

HEPARIN-INDUCED THROMBOCYTOPENIA AND ITS IMPACT ON INPATIENT OUTCOMES IN INFLAMMATORY BOWEL DISEASE.

The American journal of the medical sciences·2026

PCBP1 joins the regulatory network of the endothelial-to-hematopoietic transition.

Experimental hematology·2026

Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results.

Clinical and translational allergy·2026

Related Experiment Videos

Blood coagulation abnormalities in chronic myeloid leukaemia

Related Concept Videos

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT).

Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group.

Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia.

Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies.

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.

Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Comparison of radial artery and saphenous vein as the third conduit with bilateral internal mammary arteries in coronary bypass surgery.

Hemiarch repair versus total-arch repair with frozen elephant trunk for acute type A aortic dissection: A propensity score-matched study.

Is systemic anticoagulation necessary during intraoperative venoarterial extracorporeal membrane oxygenation for bilateral lung transplantation? A feasibility study comparing zero-, low-, and high-intensity heparin strategies.

HEPARIN-INDUCED THROMBOCYTOPENIA AND ITS IMPACT ON INPATIENT OUTCOMES IN INFLAMMATORY BOWEL DISEASE.

PCBP1 joins the regulatory network of the endothelial-to-hematopoietic transition.

Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results.

Related Experiment Videos

Blood coagulation abnormalities in chronic myeloid leukaemia

Related Concept Videos

Related Articles